FDA Asks Full DC Circ. To Undo Eagle's Orphan Drug Win
The U.S. Food and Drug Administration urged the full D.C. Circuit Wednesday to reconsider a panel's ruling that multiple manufacturers of a drug that treats the same rare medical condition are...To view the full article, register now.
Already a subscriber? Click here to view full article